Cell-mediated and serum blocking reactivity to tumor antigens in patients with malignant melanoma.
D000017:ABO Blood-Group System; D000293:Adolescent; D000328:Adult; D000362:Agar; D000368:Aged; D000936:Antigen-Antibody Complex; D000937:Antigen-Antibody Reactions; D000951:Antigens, Neoplasm; D002455:Cell Division; D002470:Cell Survival; D002478:Cells, Cultured; D002999:Clone Cells; D003601:Cytotoxicity Tests, Immunologic; D005260:Female; D006801:Humans; D007106:Immune Sera; D007111:Immunity, Cellular; D008207:Lymphatic Metastasis; D008214:Lymphocytes / Q000276:immunology*; D008297:Male; D008545:Melanoma / Q000276:immunology*; D008875:Middle Aged
D000017:ABO Blood-Group System; D000936:Antigen-Antibody Complex; D000951:Antigens, Neoplasm; D007106:Immune Sera; D000362:Agar